TCT-430 Nine-Month Angiographic and 1-Year Clinical Outcomes of the RECOVERY Study: A Randomized Trial Evaluating the Safety and Efficacy of the Combo Bio-Engineered Sirolimus-Eluting Stent Versus the Nano Polymer-Free Sirolimus-Eluting Stent in Patients with Coronary Artery Disease

Ling Tao,Zhanquan Li,Zhiyong Yin,Wenhua Lin,Yin Liu,Hui Li,Bo Yu,Wei Li,Helen Lau,Bo Xu

TCT-430 Nine-Month Angiographic and 1-Year Clinical Outcomes of the RECOVERY Study: A Randomized Trial Evaluating the Safety and Efficacy of the Combo Bio-Engineered Sirolimus-Eluting Stent Versus the Nano Polymer-Free Sirolimus-Eluting Stent in Patients with Coronary Artery Disease

2017

Ling Tao
Zhanquan Li
Zhiyong Yin
Wenhua Lin
Yin Liu
Hui Li
Bo Yu
Wei Li
Helen Lau
Bo Xu

We sought to evaluate the angiographic efficacy and clinical safety and effectiveness of the combined sirolimus-eluting CD34 antibody coated Combo stent (OrbusNeich Medical, Ft. Lauderdale, Florida) in a randomized trial designed to enable its approval by the China Food and Drug Administration.

Keywords:

Randomized controlled trial
Sirolimus
Internal medicine
Radiology
Coronary artery disease
Stent
Diabetes mellitus
Cardiology
Medicine
Surgery
in patient
food and drug administration
polymer free
clinical safety

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations